These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
24. Prevention of yellow fever in persons traveling to the tropics. Monath TP; Cetron MS Clin Infect Dis; 2002 May; 34(10):1369-78. PubMed ID: 11981733 [TBL] [Abstract][Full Text] [Related]
25. Yellow fever - prevention in travellers. Neilson AA; Mayer CA Aust Fam Physician; 2010 Aug; 39(8):570-3. PubMed ID: 20877751 [TBL] [Abstract][Full Text] [Related]
26. Yellow fever vaccination status and safety in hemodialysis patients. Facincani T; Guimarães MN; De Sousa Dos Santos S Int J Infect Dis; 2016 Jul; 48():91-5. PubMed ID: 27208638 [TBL] [Abstract][Full Text] [Related]
27. Comparative study of adverse events after yellow fever vaccination between elderly and non-elderly travellers: questionnaire survey in Japan over a 1-year period. Tanizaki R; Ujiie M; Hori N; Kanagawa S; Kutsuna S; Takeshita N; Hayakawa K; Kato Y; Ohmagari N J Travel Med; 2016 Mar; 23(3):. PubMed ID: 27021495 [TBL] [Abstract][Full Text] [Related]
28. Yellow fever vaccination coverage among children in Brazilian capitals. Veras MA; Flannery B; de Moraes JC; da Silva Teixeira AM; Luna EJ; Vaccine; 2010 Sep; 28(39):6478-82. PubMed ID: 20674878 [TBL] [Abstract][Full Text] [Related]
29. [Prescription of Yellow Fever Vaccine: The Experience of the International Vaccination Centre of the Loures-Odivelas Health Centre Group]. Martinho C; Lopes D; Bastos L; Esteves H Acta Med Port; 2018 Dec; 31(12):724-729. PubMed ID: 30684369 [TBL] [Abstract][Full Text] [Related]
30. Observational study on immune response to yellow fever and measles vaccines in 9 to 15-month old children. Is it necessary to wait 4 weeks between two live attenuated vaccines? Michel R; Berger F; Ravelonarivo J; Dussart P; Dia M; Nacher M; Rogier S; Moua D; Sarr FD; Diop OM; Sall AA; Baril L Vaccine; 2015 May; 33(20):2301-6. PubMed ID: 25843268 [TBL] [Abstract][Full Text] [Related]
31. Longitudinal myelitis associated with yellow fever vaccination. Chaves M; Riccio P; Patrucco L; Rojas JI; Cristiano E J Neurovirol; 2009 Jul; 15(4):348-50. PubMed ID: 19579072 [TBL] [Abstract][Full Text] [Related]
32. Yellow fever vaccine: an effective vaccine for travelers. Verma R; Khanna P; Chawla S Hum Vaccin Immunother; 2014; 10(1):126-8. PubMed ID: 24056028 [TBL] [Abstract][Full Text] [Related]
33. Eliminating yellow fever epidemics in Africa: Vaccine demand forecast and impact modelling. Jean K; Hamlet A; Benzler J; Cibrelus L; Gaythorpe KAM; Sall A; Ferguson NM; Garske T PLoS Negl Trop Dis; 2020 May; 14(5):e0008304. PubMed ID: 32379756 [TBL] [Abstract][Full Text] [Related]
34. An inactivated cell-culture vaccine against yellow fever. Monath TP; Fowler E; Johnson CT; Balser J; Morin MJ; Sisti M; Trent DW N Engl J Med; 2011 Apr; 364(14):1326-33. PubMed ID: 21470010 [TBL] [Abstract][Full Text] [Related]
35. Comparison of the immunogenicity and safety of two 17D yellow fever vaccines. Lang J; Zuckerman J; Clarke P; Barrett P; Kirkpatrick C; Blondeau C Am J Trop Med Hyg; 1999 Jun; 60(6):1045-50. PubMed ID: 10403341 [TBL] [Abstract][Full Text] [Related]
36. Yellow Fever Vaccine Booster Doses: Recommendations of the Advisory Committee on Immunization Practices, 2015. Staples JE; Bocchini JA; Rubin L; Fischer M; MMWR Morb Mortal Wkly Rep; 2015 Jun; 64(23):647-50. PubMed ID: 26086636 [TBL] [Abstract][Full Text] [Related]
37. Vaccinations for international travellers travelling from Greece. Pavli A; Spilioti A; Lymperi I; Katerelos P; Maltezou HC Travel Med Infect Dis; 2013; 11(4):225-30. PubMed ID: 23433917 [TBL] [Abstract][Full Text] [Related]
38. How many published cases of serious adverse events after yellow fever vaccination meet Brighton Collaboration diagnostic criteria? Thomas RE; Spragins W; Lorenzetti DL Vaccine; 2013 Dec; 31(52):6201-9. PubMed ID: 24436960 [TBL] [Abstract][Full Text] [Related]
39. Tolerance and humoral immune response to the yellow fever vaccine in sickle cell disease children treated with hydroxyurea: a multicentre prospective study. Koehl B; Aupiais C; Schinckel N; Mornand P; Odièvre MH; Niakate A; Brousse V; Ithier G; Missud F; Holvoet L; Benkerrou M; Sorge F; Faye A J Travel Med; 2021 Apr; 28(3):. PubMed ID: 33550421 [TBL] [Abstract][Full Text] [Related]
40. Preferences and decision needs of Boston-area travelers to countries with risk of Yellow fever virus transmission: implications for health care providers. Lown BA; Chen LH; Han PV; Jentes ES; Wilson ME; Benoit CM; Avery KA; Ooi W; Hamer DH; Barnett ED; J Travel Med; 2014; 21(4):266-71. PubMed ID: 24734961 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]